HHS Response to the Monkeypox Outbreak

Monkeypox is a virus spread mostly through close, intimate contact with someone who has already contracted the virus. Currently, HHS – through the Centers of Disease Control and Prevention – is tracking an outbreak of monkeypox that has spread across several countries that don’t normally report monkeypox, including the United States.

As part of the whole-of-government approach to tackling monkeypox, HHS is working closely with public health officials and other key stakeholders to ensure high-risk communities in localities across the country get vaccines, testing, and treatments.

White House National Monkeypox Response Deputy Coordinator, Dr. Demetre Daskalakis, answers some questions on monkeypox vaccines, including the intradermal route for the JYNNEOS vaccine. Prior to being appointed as Deputy Coordinator, Dr. Daskalakis served as Director of the CDC Division of HIV Prevention and is a national expert on health issues affecting the LGBTQI+ community.

Important Monkeypox Information from Around the Department

Resources from CDC

Learn more about monkeypox, how it spreads, signs and symptoms, treatments and vaccines from the Centers for Disease Control and Prevention (CDC).


Get answers to your questions on the monkeypox FAQ page.

Data from CDC

Find the latest data on monkeypox’s spread. 

ASPR Response

Learn how the Administration for Strategic Preparedness and Response (ASPR) is delivering monkeypox vaccines to public health partners in states and major metropolitan areas across the country.

JYNNEOS Vaccine Distribution

Find out how much JYNNEOS vaccine has been allocated, requested, and shipped to jurisdictions nationwide.

FDA Development and Authorization

Learn how the U.S. Food and Drug Administration (FDA) facilitates the development and availability of tests, treatments, and vaccines for monkeypox, as well as authorizes certain medical products to combat the virus for emergency use.

NIH Research

Learn about National Institutes of Health (NIH) research on monkeypox virus, including studies examining diagnostics, vaccines, and treatments.

TPOXX Thresholds by Jurisdiction

Find out how much TPOXX is being made available to jurisdictions nationwide for the treatment of individuals infected with monkeypox under Expanded Access Investigational New Drug (EA-IND).

Public Health Emergency Declaration

Read Secretary Becerra’s Public Health Emergency Determination for Monkeypox.

Content created by Assistant Secretary for Public Affairs (ASPA)
Content last reviewed